Drugs: cardiovascular system

You have access
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
Marcello Tonelli, Anita Lloyd, Fiona Clement, Jon Conly, Don Husereau, Brenda Hemmelgarn, Scott Klarenbach, Finlay A. McAlister, Natasha Wiebe and Braden Manns

CMAJ November 08, 2011 183 (16) E1189-E1202; DOI: https://doi.org/10.1503/cmaj.101280
You have access
Antidepressants, antiplatelets and bleeding: One more thing to worry about?
David N. Juurlink

CMAJ November 08, 2011 183 (16) 1819-1820; DOI: https://doi.org/10.1503/cmaj.111576
You have access
The efficacy and cost-effectiveness of statins in low-risk patients
Ajay K. Gupta

CMAJ November 08, 2011 183 (16) 1821-1823; DOI: https://doi.org/10.1503/cmaj.111674
You have access
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction
Christopher Labos, Kaberi Dasgupta, Hacene Nedjar, Gustavo Turecki and Elham Rahme

CMAJ November 08, 2011 183 (16) 1835-1843; DOI: https://doi.org/10.1503/cmaj.100912
You have access
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies
Chan Yoon, Hyun-Sik Yang, Inpyo Jeon, Yoosoo Chang and Sang Min Park

CMAJ October 04, 2011 183 (14) E1073-E1084; DOI: https://doi.org/10.1503/cmaj.101497
You have access
Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations
Meytal A. Tsadok, Cynthia A. Jackevicius, Elham Rahme, Vidal Essebag, Mark J. Eisenberg, Karin H. Humphries, Jack V. Tu, Hassan Behlouli, Jennifer Joo and Louise Pilote

CMAJ September 06, 2011 183 (12) E817-E823; DOI: https://doi.org/10.1503/cmaj.101800
You have access
Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors
Christopher O. Phillips

CMAJ April 05, 2011 183 (6) E309-E311; DOI: https://doi.org/10.1503/cmaj.110366
You have access
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis
Finlay A. McAlister, Jianguo Zhang, Marcello Tonelli, Scott Klarenbach, Braden J. Manns and Brenda R. Hemmelgarn

CMAJ April 05, 2011 183 (6) 655-662; DOI: https://doi.org/10.1503/cmaj.101333
You have access
The potential economic impact of restricted access to angiotensin-receptor blockers
Jason R. Guertin, Cynthia A. Jackevicius, Jafna L. Cox, Karin Humphries, Louise Pilote, Derek Y. So, Jack V. Tu, Harindra Wijeysundera and Stéphane Rinfret

CMAJ February 22, 2011 183 (3) E180-E186; DOI: https://doi.org/10.1503/cmaj.100787
You have access
Putting ACCOMPLISH into context: management of hypertension in 2010
Finlay A. McAlister, Robert J. Herman, Nadia A. Khan, Simon W. Rabkin, Norm Campbell and ; for the Canadian Hypertension Education Program

CMAJ October 19, 2010 182 (15) 1600-1601; DOI: https://doi.org/10.1503/cmaj.092142

Main menu

User menu

Search

Drugs: cardiovascular system

Pages

Content

Information for

About